GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Oventus Medical Ltd (ASX:OVN) » Definitions » Research & Development

Oventus Medical (ASX:OVN) Research & Development : A$0.20 Mil (TTM As of Dec. 2021)


View and export this data going back to 2016. Start your Free Trial

What is Oventus Medical Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Oventus Medical's Research & Development for the six months ended in Dec. 2021 was A$0.02 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2021 was A$0.20 Mil.


Oventus Medical Research & Development Historical Data

The historical data trend for Oventus Medical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oventus Medical Research & Development Chart

Oventus Medical Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21
Research & Development
0.24 0.27 0.39 0.57 0.19

Oventus Medical Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.19 0.39 0.01 0.18 0.02

Oventus Medical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oventus Medical  (ASX:OVN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Oventus Medical Research & Development Related Terms

Thank you for viewing the detailed overview of Oventus Medical's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Oventus Medical (ASX:OVN) Business Description

Traded in Other Exchanges
N/A
Address
1 Swann Road, Suite 1, PO Box 190, Indooroopilly, Brisbane, QLD, AUS, 4068
Oventus Medical Ltd is a medical device company. It is engaged in developing an oral appliance for the treatment of sleep apnoea and snoring. Its product includes O2Vent Optima . It offers oral appliance therapy, especially beneficial for the many people that suffer from nasal congestion, obstruction, and mouth breathing. The firm has two operating segments: Australia and North America.

Oventus Medical (ASX:OVN) Headlines

No Headlines